Anne Aasprong

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Stena AB engages in the provision of investment and shipping services. It operates through the following segments: Ferry Operations, Offshore Drilling, Shipping, Property, and New Businesses. The Ferry Operations segment is managed by Stena Line, in Scandinavia, the United Kingdom, France, Germany, Latvia, Poland, the Netherlands and Ireland. The Offshore Drilling segment develops and constructs of drilling rigs and drillships. The Shipping segment comprises ownership and leasing of oil tankers and RoRo vessels. The Property segment relates to investments in residential properties and commercial properties. The New Businesses segment includes long term financial involvement and investment in operations outside Stena’s core operating areas and takes place through the business unit Stena Adactum. The company was founded on November 18, 1939 and is headquartered in Gothenburg, Sweden.

Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark.

Victor Hasselblad AB manufactures cameras and photographic equipment. It offers lens, or components; digital backs and scanners; flexColor software for image capturing and processing applications; and lenses and accessories. The company was founded by Fritz V. Hasselblad in 1941 and is headquartered in Gothenburg, Sweden.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Hasselblad A/S develops, produces, and markets photographic equipment, as well as computer, software, hardware, and other in related business. The company was founded on June 14, 1995 and is headquartered in Frederiksberg, Denmark.

Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark.

Hasselblad Bron, Inc. distributes photographic equipment. The private company is based in Union.

OneMed AB distributes consumable medical products, devices, and technology in the healthcare industry. It also supplements its product range with services within purchasing, logistics, administration, information technology, support, education, product range planning, ordering procedures, as well as providing know-how on healthcare consequences and product management. Its product portfolio consists of products evercare, SELEFA, and BATIST. The firm offers Gloves; Surgical drapes, sets and gowns; Minor procedure sets; Protective apparel; Surgical masks and caps; Wound care and bandages; Paper and plastic protection; and Consumables. The company was founded in 2006 and is headquartered in Danderyd, Sweden.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

Kennet Lundberg AB provides accounting and bookkeeping services. The private company is based in Sweden.

Hasselblad Holding SARL is an investment holding private company based in Luxembourg, Luxembourg.

Part of AstraZeneca PLC, Cambridge Antibody Technology Group Ltd. is a holding company that oversees its subsidiaries' research, development, and exploitation of molecular engineering products. The company is based in Cambridge, UK and was founded in 1996.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.